Pyrroles and other heterocycles as inhibitors of P38 kinase

Bioorganic & Medicinal Chemistry Letters
1998.0

Abstract

Investigation of furans, pyrroles and pyrazolones identified 3-pyridyl-2,5-diaryl-pyrroles as potent, orally bioavailable inhibitors of p38 kinase. 3-(4-pyridyl-2-(4-fluoro-phenyl)-5-(4-methylsulfinylphenyl)-pyrrol e (L-167307) reduces secondary paw swelling in the rat adjuvant arthritis model: ID50 = 7.4 mg/kg/b.i.d.

Knowledge Graph

Similar Paper

Pyrroles and other heterocycles as inhibitors of P38 kinase
Bioorganic & Medicinal Chemistry Letters 1998.0
Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and pharmacological characterization of a potent, orally active p38 kinase inhibitor
Bioorganic & Medicinal Chemistry Letters 2002.0
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2000.0
p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas
Bioorganic & Medicinal Chemistry Letters 2001.0
Role of the Hydrogen Bonding Heteroatom−Lys53 Interaction between the p38α Mitogen-Activated Protein (MAP) Kinase and Pyridinyl-Substituted 5-Membered Heterocyclic Ring Inhibitors
Journal of Medicinal Chemistry 2009.0
Synthesis and biological evaluation of 3-heteroaryloxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 1999.0
Synthesis and PGE2 production inhibition of 1H-furan-2,5-dione and 1H-pyrrole-2,5-dione derivatives
Bioorganic & Medicinal Chemistry Letters 2010.0
6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1H-pyrrolo[2,3-b]pyridine (RWJ 68354):  A Potent and Selective p38 Kinase Inhibitor
Journal of Medicinal Chemistry 1998.0
The development of monocyclic pyrazolone based cytokine synthesis inhibitors
Bioorganic & Medicinal Chemistry Letters 2005.0